☰

Michael A. Farrar - Publications

Affiliations: 
Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 David NA, Lee RD, LaRue RS, Joo S, Farrar MA. Nuclear corepressors NCOR1 and NCOR2 entrain thymocyte signaling, selection, and emigration. Biorxiv : the Preprint Server For Biology. PMID 37808728 DOI: 10.1101/2023.09.27.559810  0.379
2022 Lee RD, Knutson TP, Munro SA, Miller JT, Heltemes-Harris LM, Mullighan CG, Jepsen K, Farrar MA. Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation. Nature Immunology. PMID 36316474 DOI: 10.1038/s41590-022-01343-7  0.522
2022 Tracy SI, Venkatesh H, Hekim C, Heltemes Harris LM, Knutson TP, Bachanova V, Farrar MA. Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia. Blood. PMID 35275990 DOI: 10.1182/blood.2021015341  0.3
2021 Lee RD, Munro SA, Knutson TP, LaRue RS, Heltemes-Harris LM, Farrar MA. Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation. Nature Communications. 12: 6843. PMID 34824268 DOI: 10.1038/s41467-021-27232-5  0.411
2021 Sjaastad LE, Owen DL, Tracy SI, Farrar MA. Phenotypic and Functional Diversity in Regulatory T Cells. Frontiers in Cell and Developmental Biology. 9: 715901. PMID 34631704 DOI: 10.3389/fcell.2021.715901  0.318
2021 Heltemes-Harris LM, Hubbard GK, LaRue RS, Munro SA, Yang R, Henzler CM, Starr TK, Sarver AL, Kornblau SM, Farrar MA. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia. Oncogene. PMID 34535769 DOI: 10.1038/s41388-021-02012-z  0.411
2020 Hainberger D, Stolz V, Zhu C, Schuster M, Müller L, Hamminger P, Rica R, Waltenberger D, Alteneder M, Krausgruber T, Hladik A, Knapp S, Bock C, Trauner M, Farrar MA, et al. NCOR1 Orchestrates Transcriptional Landscapes and Effector Functions of CD4 T Cells. Frontiers in Immunology. 11: 579. PMID 32318068 DOI: 10.3389/Fimmu.2020.00579  0.443
2019 Owen DL, Farrar MA. Differentiation of Thymic T Cell Progenitors to Mature Thymic T Cells. Bio-Protocol. 9: e3335. PMID 33654840 DOI: 10.21769/BioProtoc.3335  0.325
2019 Wong JB, Hewitt SL, Heltemes-Harris LM, Mandal M, Johnson K, Rajewsky K, Koralov SB, Clark MR, Farrar MA, Skok JA. B-1a cells acquire their unique characteristics by bypassing the pre-BCR selection stage. Nature Communications. 10: 4768. PMID 31628339 DOI: 10.1038/S41467-019-12824-Z  0.451
2019 Owen DL, Sjaastad LE, Farrar MA. Regulatory T Cell Development in the Thymus. Journal of Immunology (Baltimore, Md. : 1950). 203: 2031-2041. PMID 31591259 DOI: 10.4049/Jimmunol.1900662  0.423
2019 Irey EA, Lassiter CM, Brady NJ, Chuntova P, Wang Y, Knutson TP, Henzler C, Chaffee TS, Vogel RI, Nelson AC, Farrar MA, Schwertfeger KL. JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors. Proceedings of the National Academy of Sciences of the United States of America. PMID 31147469 DOI: 10.1073/Pnas.1816410116  0.33
2019 Liu B, Salgado OC, Singh S, Hippen KL, Maynard JC, Burlingame AL, Ball LE, Blazar BR, Farrar MA, Hogquist KA, Ruan HB. The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation. Nature Communications. 10: 354. PMID 30664665 DOI: 10.1038/S41467-019-08300-3  0.464
2019 Owen DL, Mahmud SA, Sjaastad LE, Williams JB, Spanier JA, Simeonov DR, Ruscher R, Huang W, Proekt I, Miller CN, Hekim C, Jeschke JC, Aggarwal P, Broeckel U, LaRue RS, ... ... Farrar MA, et al. Thymic regulatory T cells arise via two distinct developmental programs. Nature Immunology. PMID 30643267 DOI: 10.1038/S41590-018-0289-6  0.425
2019 Tracy SI, Hekim C, Farrar M. Characterization of BCR-ABL Specific CD4+ T Cells and Their Role in Controlling Ph+ Acute Lymphoblastic Leukemia Blood. 134: 1345-1345. DOI: 10.1182/Blood-2019-124205  0.426
2018 Rahrmann EP, Wolf NK, Otto GM, Heltemes Harris L, Ramsey LB, Shu J, LaRue RS, Linden MA, Rathe SK, Starr TK, Farrar MA, Moriarity BS, Largaespada DA. Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma. Molecular Cancer Research : McR. PMID 30355676 DOI: 10.1158/1541-7786.Mcr-18-0582  0.668
2018 Owen DL, Mahmud SA, Vang KB, Kelly RM, Blazar BR, Smith KA, Farrar MA. Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis. Journal of Immunology (Baltimore, Md. : 1950). PMID 29728511 DOI: 10.4049/Jimmunol.1800097  0.482
2017 Brady NJ, Farrar MA, Schwertfeger KL. STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland development. Developmental Biology. PMID 28606561 DOI: 10.1016/J.Ydbio.2017.06.007  0.394
2017 Katerndahl CD, Heltemes-Harris LM, Willette MJ, Henzler CM, Frietze S, Yang R, Schjerven H, Silverstein KA, Ramsey LB, Hubbard G, Wells AD, Kuiper RP, Scheijen B, van Leeuwen FN, Müschen M, ... ... Farrar MA, et al. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nature Immunology. PMID 28369050 DOI: 10.1038/Ni.3716  0.766
2017 Owen DL, Farrar MA. STAT5 and CD4 (+) T Cell Immunity. F1000research. 6: 32. PMID 28163905 DOI: 10.12688/F1000Research.9838.1  0.447
2017 Farrar M, Hekim C, Luke MS, Vezys V, Jenkins MK. Overcoming Leukemia-Induced Immune Suppression in BCR-ABL+ Acute Lymphoblastic Leukemia Blood. 130: 3881-3881. DOI: 10.1182/Blood.V130.Suppl_1.3881.3881  0.459
2016 Manlove LS, Schenkel JM, Manlove KR, Pauken KE, Williams RT, Vezys V, Farrar MA. Heterologous Vaccination and Checkpoint Blockade Synergize To Induce Antileukemia Immunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 27183622 DOI: 10.4049/Jimmunol.1600130  0.367
2016 Brady NJ, Farrar MA, Schwertfeger KL. Abstract B64: Macrophage-specific deletion of STAT5 disrupts normal mammary gland development and accelerates mammary tumorigenesis Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B64  0.431
2015 Heltemes-Harris LM, Larson JD, Starr TK, Hubbard GK, Sarver AL, Largaespada DA, Farrar MA. Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia. Oncogene. PMID 26500062 DOI: 10.1038/Onc.2015.405  0.543
2015 Manlove LS, Berquam-Vrieze KE, Pauken KE, Williams RT, Jenkins MK, Farrar MA. Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells. Journal of Immunology (Baltimore, Md. : 1950). 195: 4028-37. PMID 26378075 DOI: 10.4049/Jimmunol.1501291  0.422
2015 Lawson BR, Gonzalez-Quintial R, Eleftheriadis T, Farrar MA, Miller SD, Sauer K, McGavern DB, Kono DH, Baccala R, Theofilopoulos AN. Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation. Clinical Immunology (Orlando, Fla.). 161: 260-269. PMID 26319414 DOI: 10.1016/J.Clim.2015.08.007  0.468
2015 Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J, Withers DR, Hugues S, Farrar MA, Reith W, Eberl G, Baldassano RN, Laufer TM, Elson CO, Sonnenberg GF. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells. Science (New York, N.Y.). 348: 1031-5. PMID 25908663 DOI: 10.1126/Science.Aaa4812  0.408
2015 Brady NJ, Farrar MA, Schwertfeger KL. Abstract S4-01: Macrophage-specific deletion of STAT5 disrupts normal mammary gland development and accelerates mammary tumorigenesis Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-S4-01  0.41
2014 Liu GJ, Cimmino L, Jude JG, Hu Y, Witkowski MT, McKenzie MD, Kartal-Kaess M, Best SA, Tuohey L, Liao Y, Shi W, Mullighan CG, Farrar MA, Nutt SL, Smyth GK, et al. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia. Genes & Development. 28: 1337-50. PMID 24939936 DOI: 10.1016/J.Exphem.2013.05.059  0.505
2014 Mahmud SA, Manlove LS, Schmitz HM, Xing Y, Wang Y, Owen DL, Schenkel JM, Boomer JS, Green JM, Yagita H, Chi H, Hogquist KA, Farrar MA. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nature Immunology. 15: 473-81. PMID 24633226 DOI: 10.1038/Ni.2849  0.495
2013 Mahmud SA, Manlove LS, Farrar MA. Interleukin-2 and STAT5 in regulatory T cell development and function. Jak-Stat. 2: e23154. PMID 24058794 DOI: 10.4161/jkst.23154  0.368
2013 Heltemes-Harris LM, Farrar MA. Constitutively active STAT5 constructs. Methods in Molecular Biology (Clifton, N.J.). 967: 225-32. PMID 23296733 DOI: 10.1007/978-1-62703-242-1_16  0.469
2012 Zou T, Satake A, Corbo-Rodgers E, Schmidt AM, Farrar MA, Maltzman JS, Kambayashi T. Cutting edge: IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo. Journal of Immunology (Baltimore, Md. : 1950). 189: 28-32. PMID 22623329 DOI: 10.4049/Jimmunol.1200507  0.445
2012 Johnson K, Chaumeil J, Micsinai M, Wang JM, Ramsey LB, Baracho GV, Rickert RC, Strino F, Kluger Y, Farrar MA, Skok JA. IL-7 functionally segregates the pro-B cell stage by regulating transcription of recombination mediators across cell cycle. Journal of Immunology (Baltimore, Md. : 1950). 188: 6084-92. PMID 22581861 DOI: 10.4049/Jimmunol.1200368  0.704
2012 Heltemes-Harris LM, Farrar MA. The role of STAT5 in lymphocyte development and transformation. Current Opinion in Immunology. 24: 146-52. PMID 22342169 DOI: 10.1016/J.Coi.2012.01.015  0.462
2012 Hodawadekar S, Park K, Farrar MA, Atchison ML. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer. Journal of Immunology (Baltimore, Md. : 1950). 188: 2276-84. PMID 22279106 DOI: 10.4049/Jimmunol.1102239  0.517
2011 Farrar MA, Harris LM. Turning transcription on or off with STAT5: when more is less. Nature Immunology. 12: 1139-40. PMID 22089213 DOI: 10.1038/Ni.2163  0.386
2011 Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS. Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host & Microbe. 10: 54-64. PMID 21767812 DOI: 10.1016/J.Chom.2011.06.005  0.315
2011 Heltemes-Harris LM, Willette MJ, Ramsey LB, Qiu YH, Neeley ES, Zhang N, Thomas DA, Koeuth T, Baechler EC, Kornblau SM, Farrar MA. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia. The Journal of Experimental Medicine. 208: 1135-49. PMID 21606506 DOI: 10.1084/Jem.20101947  0.773
2011 Heltemes-Harris LM, Willette MJ, Vang KB, Farrar MA. The role of STAT5 in the development, function, and transformation of B and T lymphocytes. Annals of the New York Academy of Sciences. 1217: 18-31. PMID 21276004 DOI: 10.1111/J.1749-6632.2010.05907.X  0.774
2011 Dings RP, Vang KB, Castermans K, Popescu F, Zhang Y, Oude Egbrink MG, Mescher MF, Farrar MA, Griffioen AW, Mayo KH. Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3134-45. PMID 21252159 DOI: 10.1158/1078-0432.Ccr-10-2443  0.322
2011 Ramsey LB, Vegoe AL, Miller AT, Cooke MP, Farrar MA. Tonic BCR signaling represses receptor editing via Raf- and calcium-dependent signaling pathways. Immunology Letters. 135: 74-7. PMID 20933008 DOI: 10.1016/J.Imlet.2010.09.018  0.679
2010 Farrar MA. Design and use of constitutively active STAT5 constructs. Methods in Enzymology. 485: 583-96. PMID 21050937 DOI: 10.1016/B978-0-12-381296-4.00030-0  0.448
2010 Venuprasad K, Poojary KV, Kong YC, Farrar MA. Control of Th2-mediated inflammation by regulatory T cells. The American Journal of Pathology. 177: 525-31. PMID 20566752 DOI: 10.2353/Ajpath.2010.090936  0.361
2010 Vogtenhuber C, Bucher C, Highfill SL, Koch LK, Goren E, Panoskaltsis-Mortari A, Taylor PA, Farrar MA, Blazar BR. Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses. Blood. 116: 466-74. PMID 20442366 DOI: 10.1182/Blood-2009-11-252825  0.406
2010 Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, Chen W. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood. 115: 5041-52. PMID 20339095 DOI: 10.1182/Blood-2009-03-213363  0.508
2010 Vang KB, Yang J, Pagán AJ, Li LX, Wang J, Green JM, Beg AA, Farrar MA. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. Journal of Immunology (Baltimore, Md. : 1950). 184: 4074-7. PMID 20228198 DOI: 10.4049/Jimmunol.0903933  0.735
2010 Li LX, Goetz CA, Katerndahl CD, Sakaguchi N, Farrar MA. A Flt3- and Ras-dependent pathway primes B cell development by inducing a state of IL-7 responsiveness. Journal of Immunology (Baltimore, Md. : 1950). 184: 1728-36. PMID 20065110 DOI: 10.4049/Jimmunol.0903023  0.787
2010 Hewitt SL, Yin B, Ji Y, Chaumeil J, Marszalek K, Tenthorey J, Salvagiotto G, Steinel N, Ramsey LB, Ghysdael J, Farrar MA, Sleckman BP, Schatz DG, Busslinger M, Bassing CH, et al. Erratum: Corrigendum: RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci Nature Immunology. 11: 356-356. DOI: 10.1038/ni0410-356  0.533
2010 Hewitt SL, Yin B, Ji Y, Chaumeil J, Marszalek K, Tenthorey J, Salvagiotto G, Steinel N, Ramsey LB, Ghysdael J, Farrar MA, Sleckman BP, Schatz DG, Busslinger M, Bassing CH, et al. Addendum: RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci Nature Immunology. 11: 355-356. DOI: 10.1038/Ni0410-355  0.573
2009 Molinero LL, Yang J, Gajewski T, Abraham C, Farrar MA, Alegre ML. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 6736-43. PMID 19454668 DOI: 10.4049/Jimmunol.0900498  0.717
2009 Hewitt SL, Yin B, Ji Y, Chaumeil J, Marszalek K, Tenthorey J, Salvagiotto G, Steinel N, Ramsey LB, Ghysdael J, Farrar MA, Sleckman BP, Schatz DG, Busslinger M, Bassing CH, et al. RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci. Nature Immunology. 10: 655-64. PMID 19448632 DOI: 10.1038/Ni.1735  0.614
2009 Nakayama J, Yamamoto M, Hayashi K, Satoh H, Bundo K, Kubo M, Goitsuka R, Farrar MA, Kitamura D. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Blood. 113: 1483-92. PMID 19047679 DOI: 10.1182/Blood-2008-07-166355  0.558
2008 Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, Farrar MA. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. Journal of Immunology (Baltimore, Md. : 1950). 181: 3285-90. PMID 18714000 DOI: 10.4049/Jimmunol.181.5.3285  0.647
2008 Welner RS, Pelayo R, Nagai Y, Garrett KP, Wuest TR, Carr DJ, Borghesi LA, Farrar MA, Kincade PW. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection Blood. 112: 3753-3761. PMID 18552210 DOI: 10.1182/Blood-2008-04-151506  0.404
2008 Schram BR, Tze LE, Ramsey LB, Liu J, Najera L, Vegoe AL, Hardy RR, Hippen KL, Farrar MA, Behrens TW. B cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements. Journal of Immunology (Baltimore, Md. : 1950). 180: 4728-41. PMID 18354197 DOI: 10.4049/Jimmunol.180.7.4728  0.705
2008 Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio CW, Vegoe AL, Hsieh CS, Jenkins MK, Farrar MA. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity. 28: 112-21. PMID 18199418 DOI: 10.1016/J.Immuni.2007.11.022  0.728
2008 Nie L, Perry SS, Zhao Y, Huang J, Kincade PW, Farrar MA, Sun XH. Regulation of lymphocyte development by cell-type-specific interpretation of Notch signals. Molecular and Cellular Biology. 28: 2078-90. PMID 18195039 DOI: 10.1128/Mcb.00844-07  0.537
2007 Burchill MA, Yang J, Vang KB, Farrar MA. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunology Letters. 114: 1-8. PMID 17936914 DOI: 10.1016/J.Imlet.2007.08.005  0.686
2007 Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 280-90. PMID 17182565 DOI: 10.4049/Jimmunol.178.1.280  0.702
2007 Seki Y, Yang J, Okamoto M, Tanaka S, Goitsuka R, Farrar MA, Kubo M. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs. Journal of Immunology (Baltimore, Md. : 1950). 178: 262-70. PMID 17182563 DOI: 10.4049/Jimmunol.178.1.262  0.713
2006 Taylor DK, Walsh PT, LaRosa DF, Zhang J, Burchill MA, Farrar MA, Turka LA. Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engagement of CD4+ T cells in steady-state homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 177: 2216-23. PMID 16887981 DOI: 10.4049/Jimmunol.177.4.2216  0.502
2006 Will WM, Aaker JD, Burchill MA, Harmon IR, O'Neil JJ, Goetz CA, Hippen KL, Farrar MA. Attenuation of IL-7 receptor signaling is not required for allelic exclusion. Journal of Immunology (Baltimore, Md. : 1950). 176: 3350-5. PMID 16517702 DOI: 10.4049/Jimmunol.176.6.3350  0.793
2005 Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Johanns TM, Farrar MA. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment. Journal of Immunology (Baltimore, Md. : 1950). 174: 7753-63. PMID 15944278 DOI: 10.4049/Jimmunol.174.12.7753  0.816
2004 Bensinger SJ, Walsh PT, Zhang J, Carroll M, Parsons R, Rathmell JC, Thompson CB, Burchill MA, Farrar MA, Turka LA. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 172: 5287-96. PMID 15100267 DOI: 10.4049/Jimmunol.172.9.5287  0.419
2004 Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Farrar MA. STAT5 activation underlies IL7 receptor-dependent B cell development. Journal of Immunology (Baltimore, Md. : 1950). 172: 4770-8. PMID 15067053 DOI: 10.4049/Jimmunol.172.8.4770  0.825
2003 Burchill MA, Goetz CA, Prlic M, O'Neil JJ, Harmon IR, Bensinger SJ, Turka LA, Brennan P, Jameson SC, Farrar MA. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. Journal of Immunology (Baltimore, Md. : 1950). 171: 5853-64. PMID 14634095 DOI: 10.4049/Jimmunol.171.11.5853  0.791
2003 Goetz CA, O'Neil JJ, Farrar MA. Membrane localization, oligomerization, and phosphorylation are required for optimal raf activation. The Journal of Biological Chemistry. 278: 51184-9. PMID 14530258 DOI: 10.1074/Jbc.M309183200  0.741
2003 Prlic M, Blazar BR, Farrar MA, Jameson SC. In vivo survival and homeostatic proliferation of natural killer cells. The Journal of Experimental Medicine. 197: 967-76. PMID 12695488 DOI: 10.1084/Jem.20021847  0.391
2000 Farrar MA, Olson SH, Perlmutter RM. Coumermycin-induced dimerization of GyrB-containing fusion proteins Methods in Enzymology. 327: 421-429. PMID 11045000 DOI: 10.1016/S0076-6879(00)27293-5  0.426
2000 Farrar MA, Tian J, Perlmutter RM. Membrane localization of Raf assists engagement of downstream effectors Journal of Biological Chemistry. 275: 31318-31324. PMID 10913130 DOI: 10.1074/Jbc.M003399200  0.347
1998 Li X, Steeber DA, Tang MLK, Farrar MA, Perlmutter RM, Tedder TF. Regulation of L-selectin-mediated rolling through receptor dimerization Journal of Experimental Medicine. 188: 1385-1390. PMID 9763619 DOI: 10.1084/Jem.188.7.1385  0.301
1998 Farrar MA, Doerfler P, Sauer K. Signal transduction pathways regulating the development of αβ T cells Biochimica Et Biophysica Acta - Reviews On Cancer. 1377: F35-F78. PMID 9659403 DOI: 10.1016/S0304-419X(97)00038-3  0.418
1997 Iritani BM, Forbush KA, Farrar MA, Perlmutter RM. Control of B cell development by Ras-mediated activation of Raf Embo Journal. 16: 7019-7031. PMID 9384581 DOI: 10.1093/Emboj/16.23.7019  0.457
1996 Farrar MA, Alberola-Ila J, Perlmutter RM. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization Nature. 383: 178-181. PMID 8774884 DOI: 10.1038/383178A0  0.328
1994 Greenlund A, Farrar M, Viviano B, Schreiber R. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). The Embo Journal. 13: 1591-1600. DOI: 10.1002/J.1460-2075.1994.Tb06422.X  0.529
1993 Schreiber RD, Farrar MA. The biology and biochemistry of interferon-gamma and its receptor Gastroenterologia Japonica. 28: 88-94. PMID 8486235 DOI: 10.1007/Bf02782897  0.584
1993 Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor Annual Review of Immunology. 11: 571-611. PMID 8476573 DOI: 10.1146/Annurev.Iy.11.040193.003035  0.525
1992 Schreiber RD, Farrar MA, Hershey GK, Fernandez-Luna J. The structure and function of interferon-γ receptors International Journal of Immunopharmacology. 14: 413-419. PMID 1535615 DOI: 10.1016/0192-0561(92)90171-G  0.549
1992 Farrar MA, Campbell JD, Schreiber RD. Identification of a functionally important sequence in the C terminus of the interferon-γ receptor Proceedings of the National Academy of Sciences of the United States of America. 89: 11706-11710. PMID 1465386 DOI: 10.1073/Pnas.89.24.11706  0.537
1989 Gray PW, Leong S, Fennie EH, Farrar MA, Pingel JT, Fernandez-Luna J, Schreiber RD. Cloning and expression of the cDNA for the murine interferon γ receptor Proceedings of the National Academy of Sciences of the United States of America. 86: 8497-8501. PMID 2530582 DOI: 10.1073/Pnas.86.21.8497  0.544
Show low-probability matches.